Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • Information about cancer and COVID-19
    • Culturally and Linguistically Diverse (CALD)
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Melanoma of the skin

melanoma-mm affected-cancer/cancer-types/melanoma/what-melanoma
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Statistics

Melanoma of the skin statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Melanoma skin cancer incorporates ICD-10 cancer code C43 (Malignant neoplasm of skin).


Estimated number of new cases of melanoma of the skin diagnosed in 2020

16,221 = Male icon PNG 9,480 males + Female icon PNG 6,741 females


Estimated % of all new cancer cases diagnosed in 2020

11%


Estimated number of deaths from melanoma of the skin in 2020

1,375 =  Male icon PNG 891 males + Female icon PNG 484 females


Estimated % of all deaths from cancer in 2020

2.9%


Chance of surviving at least 5 years (2012–2016)

92%


People living with melanoma of the skin at the end of 2015 (diagnosed in the 5 year period 2011 to 2015)

57,395


New cases

Melanoma of the skin was the 4th most commonly diagnosed cancer in Australia in 2016. It is estimated that it will be the 3rd most commonly diagnosed cancer in 2020.

In 2016, there were 14,485 new cases of melanoma of the skin diagnosed in Australia (8,455 males and 6,030 females). In 2020, it is estimated that 16,221 new cases of melanoma of the skin will be diagnosed in Australia (9,480 males and 6,741 females).

Figure 1. Estimated most common cancers diagnosed, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

In 2016, the age-standardised incidence rate was 54 cases per 100,000 persons (65 for males and 44 for females). In 2020, it is estimated that the age-standardised incidence rate will remain at 54 cases per 100,000 persons (66 for males and 44 for females). The incidence rate for melanoma of the skin is expected to increase with age.

Figure 2. Age-standardised incidence rates for melanoma of the skin, 1982 to 2016, by sex

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for melanoma skin cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

The number of new cases of melanoma of the skin diagnosed increased from 3,543 (1,740 males and 1,803 females) in 1982 to 14,485 in 2016. Over the same period, the age-standardised incidence rate increased from 27 cases per 100,000 persons (28 for males and 26 for females) in 1982 to 54 cases per 100,000 in 2016.

Deaths 

Melanoma of the skin was the 9th most common cause of death in Australia in 2018. It is estimated that it will be the 10th most common cause of death in 2020.

In 2018, there were 1,429 deaths from melanoma of the skin in Australia (965 males and 464 females). In 2020, it is estimated that there will be 1,375 deaths (891 males and 484 females).

Figure 3. Estimated most common causes of cancer death, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

In 2018, the age-standardised mortality rate was 4.7 deaths per 100,000 persons (7.0 for males and 2.9 for females). In 2020, it is estimated that the age-standardised mortality rate will be 4.3 deaths per 100,000 persons (6.1 for males and 2.8 for females). The mortality rate for melanoma of the skin is expected to increase with age.

Figure 4. Age-standardised mortality rates for melanoma of the skin, 1982 to 2018, by sex

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for melanoma skin cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

The number of deaths from melanoma of the skin increased from 596 (380 males and 216 females) in 1982 to 1,429 in 2018. Over the same period, the age-standardised mortality rate was 4.7 deaths per 100,000 persons in 1982 (6.4 for males and 3.2 for females) and remained at 4.7 in 2018. 

Survival 

In 2012–2016, individuals diagnosed with melanoma of the skin had a 92 % chance (90% for males and 94% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2012–2016, five-year relative survival for melanoma of the skin improved from 88% to 92%.

Figure 5. 5-year relative survival from melanoma skin cancer, 1986–1990 to 2011–2015, by sex 

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about 5-year relative survival rates for melanoma skin cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival) 

Prevalence 

At the end of 2015, there were 13,456 people living who had been diagnosed with melanoma of the skin that year, 57,395 people living who had been diagnosed with melanoma of the skin in the previous 5 years (from 2011 to 2015) and 191,270 people living who had been diagnosed with melanoma of the skin in the previous 34 years (from 1982 to 2015).

For more information, see Melanoma skin cancer on the NCCI website 

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Cancer Council Australia, Melanoma
National Cancer Institute (US)
American Cancer Society

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia